News und Analysen

Shares of AbbVie (NYSE: ABBV) were jumping 7.1% higher as of 11:10 a.m. ET on Friday after rising as much as 9.2% earlier in the day. The nice gain stemmed from the big drugmaker's 2024

ResMed (NYSE:RMD), a leader in sleep apnea and respiratory care solutions, reported strong fiscal 2025 second-quarter earnings on Thursday, Jan. 30. The medical device company outperformed analyst

Shares of Cigna (NYSE: CI) were dropping Thursday. The stock was down 8.4% as of 1:20 p.m. ET but had lost as much as 11.3% earlier in the day. The leg down comes as the S&P 500 gained 0.2% and the

Image source: The Motley Fool.

Cigna Group (NYSE: CI)Q4 2024 Earnings CallJan 30, 2025, 8:30 a.m. ET

Operator

Continue reading

Source Fool.com

It takes money to make money. However, you don't need a lot to get started. Many top-notch dividend stocks have share prices below $100 right now.

That's worth noting, given the powerful returns

Shares of Medtronic (NYSE: MDT) are off to a fantastic start in 2025, already rising by 13% year to date. The medical devices giant had some weakness in recent years amid disappointing trends from

Monday was a grim day for a great many stocks, but luckily for its investors, AbbVie (NYSE: ABBV) wasn't one of them. The storied pharmaceutical company saw its share price rise by almost 4%, on the

Dividend stocks can be a great way to boost your portfolio's growth potential or provide a form of passive income over the years. While not all dividend stocks are the same, finding great companies

The healthcare sector has struggled to deliver worthwhile returns for investors since 2021, weighed down by several headwinds. Rising interest rates, challenges in the U.S. healthcare system, and

When you're buying income stocks, a company's underlying business is arguably still the most crucial factor to consider, even more than the dividend yield. Corporations with high yields may look

Some people make it a New Year's resolution to improve their finances by investing in stocks. It's a laudable goal, and to get started, it's crucial to pick stocks that have the tools to perform

If you're a dividend investor, I can understand why -- because dividend-paying stocks offer a triple upside: As long as the underlying company is healthy and growing, its stock price will likely

Pharmaceutical powerhouse AbbVie (NYSE: ABBV) has been a beast since it spun off from Abbott Laboratories in 2012. Over the past decade, the stock has averaged a dividend yield of 3.5% while raising

If you're a new investor, want some recurring dividend income, or just want some top stocks to build your portfolio around, it's important to focus on businesses with strong fundamentals and room to

In 2022, pharmaceutical giant Pfizer (NYSE: PFE) became the first healthcare company to generate $100 billion in annual sales. But since that notable achievement, its financial results have fallen

Image source: The Motley Fool.

Abbott Laboratories (NYSE: ABT)Q4 2024 Earnings CallJan 22, 2025, 9:30 a.m. ET

Operator

Continue reading

Source Fool.com

Pharmaceutical giant Pfizer (NYSE: PFE) is trading near its lowest price in over a decade.

The company's revenue and profits ballooned during the pandemic on its COVID-19 vaccine and treatment. Then

How expensive is the stock market right now? The S&P 500 Shiller CAPE ratio is near its second-highest level ever. Its highest mark came in early 2000 before the dot-com bubble burst. The

Many products sold by companies aren't must-have items. However, healthcare is a necessity. And the healthcare sector is poised to grow over the next decade and beyond with aging populations around

Investors seeking a steadily growing passive income stream want to turn their heads toward the healthcare sector. Unlike with enterprise software sales or consumer goods, spending on healthcare

You can look at the momentum for some stocks and have a feeling that it's about to end. Others, though, have such strong underlying business prospects that they're practically unstoppable.

Three

Image source: The Motley Fool.

UnitedHealth Group (NYSE: UNH)Q4 2024 Earnings CallJan 16, 2025, 8:45 a.m. ET

Operator

Continue reading

Source Fool.com

Shares of UnitedHealth Group (NYSE: UNH) were pulling back Thursday after the company delivered underwhelming fourth-quarter results, as sales were weaker than expected and its costs rose.

 As of

Some investors believe you make money when you buy a stock, not when you sell it. The logic behind this idea is that investing in the right stock at the right time -- and holding onto it for a while

It usually doesn't matter if you buy a given stock immediately or two weeks later. Sure, the stock could move up or down but typically not enough to matter all that much.

However, there are